Vantage Consulting Group Inc Organogenesis Holdings Inc. Transaction History

Vantage Consulting Group Inc

  • $7.71 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$2.48 - $3.43 $6,641 - $9,185
2,678 Added 14.52%
21,123 $56,000
Q3 2022

Nov 14, 2022
BUY
$3.14 - $6.43 $24,878 - $50,944
7,923 Added 75.3%
18,445 $60,000
Q2 2022

Aug 09, 2022
BUY
$4.74 - $8.15 $49,874 - $85,754
10,522 New
10,522 $51,000

Others Institutions Holding ORGO

# of Institutions
118
Shares Held
64.3M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $462M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email